Table 4.

Risk for HBsAg and HBeAg Seropositivity Relative to Biochemical Markers among Study Participants

	OR(95% CI)
	Abnormal ALT test	Abnormal AST test	Abnormal γ-GT test
HBsAg (+) subjects	2.66(1.80-3.05)	3.88(2.62-4.15)	1.06(0.52-1.46)
HBsAg (-) subjects	1(reference)
HBsAg (+) and HBeAg (+) subjects	3.12(2.12-4.05)	2.81(2.01-3.79)	1.14(0.35-4.50)
HBsAg (+) and HBeAg (-) subjects	1(reference)

HBsAg, hepatitis B surface antigen; HBeAg, hepatitis B e antigen; ALT, alanine aminotransferase; AST, aspartate aminotransferase; γ-GTP, γ-glutamyl transpeptidase;

Odds ratios with 95% confidence intervals were adjusted for region of residence, drinking, smoking, sleep quality, blood transfusion, blood donation, family size, ethnicity, occupation, education level, income, gender, BMI, age, fatty liver, and hyperlipidemia.